4 ms·
> Our brand name was a disaster and most of the traffic that we got, for free, was looking for an alternate name called “Eliquis” a drug from Bayer. There was n
by ravitation 9y ago
> Our brand name was a disaster and most of the traffic that we got, for free, was looking for an alternate name called “Eliquis” a drug from Bayer. There was no way we would win the SEO game. We had no SEO strategy or any other ecosystem strategy to piggyback our marketing on.
First thought was definitely to the blood thinner... Which is an interesting commentary on the state of direct to consumer pharmaceutical marketing in the United States...
- roynal 9y agoAbsolutely the blood thinner won and it's a hard lesson that we learned.
- ravitation 9y agoMy point was not so much about losing a battle over name recognition, that's something that happens relatively all the time. I mean specifically losing it, even to the general public that isn't on blood thinners (like myself), to a blood thinner. In a lot of developed countries, where direct to consumer pharmaceutical advertising isn't legal this obviously would not have happened...